NETRI, Techbio neuro-organs-on-chip start-up, announces the signature of a scientific collaboration agreement with French Agency for Food, Environmental and Occupational Health and Safety (Anses). The aim of this joint research project is to develop new methods for assessing the toxicity of pesticides on the human nervous system, without recourse to animal testing.
NETRI, start-up industrielle Techbio de neuro-organes-sur-puce annonce la signature d’un accord de collaboration scientifique avec l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (Anses). Ce projet de recherche commun vise au développement de nouvelles méthodes permettant l’évaluation de la toxicité des pesticides sur le système nerveux humain, sans recours aux tests sur animaux.
Reprise des actifs de la biotech HCS Pharma, Article dans un journal néerlandais, Prix DVES… Découvrez notre revue de presse du mois d’avril & mai 2025.
NETRI récompensée par Auvergne-Rhône-Alpes Entreprises avec le Trophée Coup de cœur – Trophées d’Innovation Industrielle 2025.
On April 10, the U.S. Food and Drug Administration (FDA) released a strategic roadmap to phase out the requirement for animal testing in the preclinical evaluation of monoclonal antibodies (mAbs) and other drugs.
NETRI, an industrial start-up specializing in neuro organs-on-chip combined with AI, announces the acquisition of HCS PHARMA assets. This strategic operation is fully in line with NETRI’s development plan and strengthens its technological offering by integrating patented innovations in biomaterials and advanced cellular models.
ORGANS-ON-CHIP KITS
Quickly and easily adopt organs-on-chip
into users’ research
